• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Metronidazole conquers EAC

Article

Washington - Systemic metronidazole can be an effective treatment for erythema annulare centrifugum (EAC), according to Lucio Andreassi, M.D., professor and chairman of the Department of Dermatology at the University of Siena, Italy. At the annual AAD meeting, Dr. Andreassi presented a case report of a patient with a two-year history of EAC who was successfully treated with a six-week course of oral metronidazole, followed by a four-week course of topical metronidazole 1 percent gel.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.